BR9609631A - Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca - Google Patents

Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca

Info

Publication number
BR9609631A
BR9609631A BR9609631A BR9609631A BR9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A
Authority
BR
Brazil
Prior art keywords
isochromans
disubstituted
treatment
migraine headaches
headaches
Prior art date
Application number
BR9609631A
Other languages
English (en)
Portuguese (pt)
Inventor
Ruth E Tenbrink
Michael D Enis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9609631A publication Critical patent/BR9609631A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9609631A 1995-06-30 1996-06-07 Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca BR9609631A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (fr) 1995-06-30 1996-06-07 Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine

Publications (1)

Publication Number Publication Date
BR9609631A true BR9609631A (pt) 1999-03-02

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609631A BR9609631A (pt) 1995-06-30 1996-06-07 Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca

Country Status (12)

Country Link
EP (1) EP0836599A1 (fr)
JP (1) JPH11509532A (fr)
AU (1) AU6252296A (fr)
BR (1) BR9609631A (fr)
CA (1) CA2225282A1 (fr)
CZ (1) CZ418597A3 (fr)
FI (1) FI974640A0 (fr)
MX (1) MX9710260A (fr)
NO (1) NO976112L (fr)
PL (1) PL324319A1 (fr)
SK (1) SK164297A3 (fr)
WO (1) WO1997002259A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (pt) 2004-05-05 2007-11-20 Hoffmann La Roche arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos
WO2006066756A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de chromane utiles dans le traitement des troubles du systeme nerveux central
SI1831159T1 (sl) 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
WO2006066748A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de tetraline et d'indane et utilisations de ceux-ci en tant qu'antagonistes de la 5-ht
DE602005017663D1 (de) 2004-12-21 2009-12-24 Hoffmann La Roche Tetralin- und indanderivate und anwendungen davon
CA2592001A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de chromane et utilisation de ces derniers comme ligands du recepteur 5-ht
BRPI0618206A2 (pt) 2005-11-03 2011-08-23 Hoffmann La Roche arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos
MX2008015843A (es) 2006-06-20 2009-01-09 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos.
CA2655524A1 (fr) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Derives d'arylsulfonamidyl tetraline et leurs utilisations
EP2041079A1 (fr) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Derives arylsulfonylnaphtalene et leurs utilisations
EP2404897A4 (fr) * 2009-03-05 2014-02-26 Sumitomo Chemical Co Procédé de production de benzène diméthanol à substitution halogène

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
ES2133714T3 (es) * 1993-12-28 1999-09-16 Upjohn Co Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.

Also Published As

Publication number Publication date
NO976112D0 (no) 1997-12-29
JPH11509532A (ja) 1999-08-24
PL324319A1 (en) 1998-05-25
SK164297A3 (en) 1998-09-09
CA2225282A1 (fr) 1997-01-23
MX9710260A (es) 1998-03-29
NO976112L (no) 1998-03-02
CZ418597A3 (cs) 1998-06-17
FI974640A (fi) 1997-12-30
WO1997002259A1 (fr) 1997-01-23
AU6252296A (en) 1997-02-05
FI974640A0 (fi) 1997-12-30
EP0836599A1 (fr) 1998-04-22

Similar Documents

Publication Publication Date Title
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
ZA97631B (en) Migraine treatment.
BR9609631A (pt) Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca
EP0820467A4 (fr) Procedes de traitement de troubles oculaires
PT752870E (pt) Utilizacao de mycobacterium para o tratamento de tumores
DE69515997D1 (de) Transkodierer
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
IT1292552B1 (it) Dispositivo per l'applicazione di rivestimenti.
BR9605759A (pt) Processo contínuo para preparação de 4-mino-2,2,6,6-tetrametilpiperidina
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
FI972058A0 (fi) Foerfarande foer reglering av en saendares effekt och regleringsarrangemang
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
ZA965548B (en) 1,6-disubstituted isochromans for treatment of migraine headaches
HUP9802226A3 (en) 1,6-disubstituted isochromans for treatment of migraine headaches
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
IT1295973B1 (it) Procedimento per l'illuminazione di oggetti.
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
ES1029021Y (es) Larguero para la formacion de estanterias.
ITTV940061A0 (it) "pedana, particolarmente per la pratica della scherma".
FI941868A0 (fi) Foerfarande foer hantering av avfallskaerl i anslutning till sopbil och motsvarande anordningar
FI973824A0 (fi) Foerfarande och maetningsapparat i samband med en traebehandlingsanordning
ITTO940097V0 (it) Dispositivo trituratore, particolarmente per la triturazione di carti-lagine.
FI954263A0 (fi) Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law